A Phase I Study of CDX-622

Clinical trial NCT06650761 · COMPLETED

Trial details

NCT number: NCT06650761
Sponsor: Celldex Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2024-11-01
Primary completion: 2026-04-24
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.